Melanoma on the Scalp: Signs, Dangers, and Treatment

Scalp melanoma is one of the most lethal forms of skin cancer, carrying substantially worse survival odds than melanoma on the arms, legs, or trunk. Literature reviews describe a ten-year survival rate of roughly 60%, a figure grim enough to earn it the label “invisible killer.”¹ The combination of difficult self-detection, aggressive tumor biology, and a rich network of blood vessels beneath the scalp makes this a location where melanoma thrives quietly and spreads fast.

Why Location Matters So Much

Melanoma on the scalp and neck behaves differently from melanoma almost anywhere else on the body. A large population-based study using national cancer registry data found that patients with scalp or neck melanoma died of the disease at nearly twice the rate of patients with melanoma on the extremities, even after accounting for tumor thickness, age, sex, and ulceration. The five-year survival for scalp and neck melanoma was about 83%, compared with roughly 92% for other body sites. At ten years, the gap widened further: about 76% versus almost 89%.²

A separate study focused specifically on scalp melanoma patients who already had advanced disease found even starker numbers. Median overall survival was about 26 months for scalp melanoma versus nearly 29 months for other sites, and five-year overall survival was around 44% versus 63%.³ Part of the explanation may be biological: the scalp has an unusually dense blood supply, and researchers have proposed that melanoma cells in this area behave somewhat like cancers that naturally tend to invade blood vessels and spread through the bloodstream rather than only through lymph nodes.⁴ Scalp melanomas also tend to have a high rate of cell division, which correlates with faster growth and poorer outcomes.³

Who Is Most at Risk

Scalp melanoma is overwhelmingly a disease of older men. In one large population-level study, more than three-quarters of patients were male, and the average age at diagnosis was about 63. Older age and male sex were both independently linked to worse survival.⁵ A separate study of invasive scalp melanoma confirmed the male skew, finding that men had nearly three times the odds of developing invasive disease compared with women.⁶

Hair loss appears to play a meaningful role. A cohort study of men found that male pattern baldness was associated with roughly a sevenfold increase in the risk of scalp melanoma specifically, while no similar increase was seen for skin cancers on other parts of the head and neck.⁷ The logic is fairly intuitive: hair acts as a physical shield against ultraviolet radiation, and as thinning progresses, the scalp receives more cumulative UV exposure. Research has also noted that androgenetic alopecia (the medical term for common pattern baldness) was significantly associated with sun damage in scalp skin and with dermoscopic signs of chronic UV injury.⁸

This does not mean women or people with full heads of hair are immune. Women do develop scalp melanoma, though at lower rates, and the scalp can sustain UV damage even through thin or fine hair, especially along the part line. Frequent sunburns on the scalp during childhood and outdoor occupations are risk factors worth taking seriously regardless of sex.

What Scalp Melanoma Looks Like

Scalp melanoma often does not look the way people expect skin cancer to look. The standard “ABCDE” checklist (asymmetry, border irregularity, color variation, diameter, evolution) was designed mainly for the flat, pigmented melanomas that appear on readily visible skin. On the scalp, the picture is frequently different.

Research shows that scalp melanomas tend to be thicker at diagnosis than melanomas in other head and neck locations, with a median thickness of about 2.8 mm compared with 1.2 mm elsewhere on the head and neck. They are more likely to be the nodular subtype, which grows outward as a raised bump rather than spreading flat across the skin. They are also more commonly amelanotic, meaning they can be pink, red, or skin-colored rather than the dark brown or black most people associate with melanoma.⁶ A pink nodule on the scalp might be mistaken for a cyst, an irritated follicle, or an age spot. That mismatch between expectation and reality is one reason scalp melanomas are caught so late.

In practical terms, you should be suspicious of any new or changing spot on the scalp, especially if it is:

Raised or dome-shaped: nodular melanomas grow upward and can feel firm to the touch
Non-pigmented: pink, red, or flesh-colored bumps that do not look like a “typical” mole
Growing quickly: faster growth rate is independently associated with invasive disease on the scalp
Bleeding or crusting: a spot that bleeds with minor trauma or does not heal deserves prompt evaluation

The Detection Problem

The most dangerous feature of scalp melanoma might not be biological at all. It is the simple fact that people cannot easily see the top of their own heads. Self-examination of the scalp is difficult to do thoroughly, and that delay in detection is thought to be one of the main reasons scalp melanomas present at a more advanced stage.⁹ A study of how scalp melanomas were first noticed found that being discovered by someone other than the patient, a spouse, or a doctor was actually associated with a higher risk of invasive disease, likely because by the time a casual acquaintance notices a spot, it has already been growing for some time.⁶

This is where hairdressers enter the picture. Hairdressers have repeated close-up access to their clients’ scalps, and case reports have documented melanomas first spotted during haircuts. One study found that hairdressers detected about 10% of all scalp and neck melanomas, and melanomas found this way were diagnosed in patients who were on average 13 years younger, tended to be thinner, and were more often caught at an earlier stage than melanomas detected by other means.¹⁰ Researchers have argued that brief training programs for hairstylists could function as a genuinely useful screening intervention for a cancer that otherwise slips through the cracks. If your barber or stylist ever mentions a funny-looking spot on your head, take it seriously.

For your own part, asking a partner or close friend to check your scalp periodically under bright light is a reasonable habit, especially if you are a man over 50, have thinning hair, or have a history of sunburns on the scalp. A handheld mirror and a well-lit bathroom can get you partway there, but having someone else look is more reliable.

How Scalp Melanoma Is Diagnosed

A dermatologist examining a suspicious scalp lesion typically starts with dermoscopy, which uses a handheld magnifying instrument with polarized light to see structural features not visible to the naked eye. On the scalp, dermoscopy faces unique challenges because hair follicles, sebaceous glands, and sun-damaged skin create visual noise that can mimic or obscure melanoma features. Research on flat scalp melanomas found that the most common melanoma subtypes on the scalp showed multicomponent, asymmetrical dermoscopic patterns, in contrast to benign moles, which typically displayed regular, symmetric patterns with a homogeneous appearance.¹¹ Atypical pigment networks and unusual blood vessel patterns are among the features that raise suspicion.

If a lesion looks worrisome, biopsy is the definitive next step. A punch biopsy or excisional biopsy removes tissue for microscopic examination. Staging follows the same general rules as melanoma elsewhere: tumor thickness, ulceration, and the presence of mitotic figures all factor in. However, sentinel lymph node biopsy, which maps and removes the first lymph node to which a tumor drains, tends to be more technically challenging on the scalp. The lymphatic drainage of the scalp is variable and unpredictable, meaning the sentinel node might be in the neck, behind the ear, or in other locations that are harder to access than the more straightforward drainage patterns from an arm or leg.¹ Scalp melanomas are also independently associated with satellite metastases, which are small clusters of tumor cells found near the primary site, adding another layer of complexity to staging.⁶

Surgical Treatment and Scalp Reconstruction

Surgery remains the primary treatment for localized scalp melanoma, but operating on the scalp introduces practical problems that do not come up elsewhere. The scalp is a thin, relatively inelastic layer of tissue stretched over a curved bone. Wide excision with adequate margins is the goal, but achieving clear margins on the scalp can be difficult, and the resulting defect often cannot simply be stitched closed the way a wound on the back or leg can.

How the wound is repaired depends on its size and depth. Smaller defects can often be closed with local tissue rearrangement, where nearby scalp skin is rotated or advanced to cover the gap. This approach is preferred when a hair-bearing result is important. Larger defects frequently require skin grafts, and in bald patients a split-thickness skin graft, sometimes placed over a dermal substitute to improve thickness and quality, can produce an acceptable result. When defects are very large, when the bone underneath has been involved, or when the area has been irradiated, free tissue transfer from another part of the body may be the safest reconstruction option.¹² In practice, the most commonly used techniques across large case series are skin grafts and local flaps, with free flaps reserved for the most complex cases.¹³

The depth of surgical excision also matters for disease control. One study found that a deeper resection plane, cutting below the tough connective tissue layer known as the galea, was actually associated with lower disease-free survival compared with a more superficial plane. That counterintuitive finding may reflect the fact that deeper resections tend to be performed on more aggressive tumors rather than that the deeper cut itself worsens outcomes, but it underscores how much the surgical details of scalp melanoma management are debated and individualized.

Systemic Therapy and the Mutation Landscape

When scalp melanoma has spread beyond the original site, systemic therapy becomes essential. The two main pillars are immunotherapy, which uses drugs that help the immune system recognize and attack melanoma cells, and targeted therapy aimed at specific genetic mutations in the tumor.

The genetic profile of scalp melanoma, however, can differ from what oncologists see in melanomas on less sun-exposed skin. The scalp is often chronically sun-damaged, and chronic sun-damaged melanomas make up roughly 10% to 20% of all cutaneous melanomas. These tumors carry a high overall mutation burden but are less likely to harbor the most common melanoma-driving mutation, BRAF V600E. Instead, they show an increased frequency of other mutations including BRAF V600K, NF1, and TP53.¹⁴ This matters because the FDA-approved targeted therapies for melanoma, combinations of BRAF and MEK inhibitors like dabrafenib plus trametinib or vemurafenib plus cobimetinib, are effective primarily against BRAF V600-mutated tumors.¹⁵ A scalp melanoma that does not carry the V600E mutation may still respond to a V600K-targeted regimen, but NF1-driven tumors, for instance, require a different approach entirely.

Immunotherapy with checkpoint inhibitors (anti-PD-1 drugs like pembrolizumab and nivolumab, sometimes combined with anti-CTLA-4 agents) has become the backbone of treatment for advanced melanoma regardless of mutation status. Because chronic sun-damaged melanomas tend to have a high mutation burden, there is theoretical reason to believe they may respond well to immunotherapy, since more mutations can mean more potential targets for the immune system to recognize. In practice, the evidence on whether scalp melanoma specifically responds differently to immunotherapy than melanoma elsewhere remains limited, and treatment decisions are typically guided by tumor stage and molecular testing rather than anatomic site alone.

Recurrence and What Drives It

Scalp melanoma has a notable tendency to recur. Head and neck location is itself a risk factor for systemic recurrence, meaning spread to distant organs, alongside tumor thickness, ulceration, and the presence of cancer cells in lymphatic or blood vessels.¹⁶ Local recurrence near the original surgical site is also a concern, particularly given the challenges of achieving wide margins on the scalp.

Follow-up after scalp melanoma surgery tends to be more intensive than for melanoma in other locations. Most guidelines call for regular skin examinations, imaging at intervals determined by the original stage, and careful monitoring of the surgical site and regional lymph node basins. Because the scalp drains to multiple lymph node groups and recurrence can appear in the neck, behind the ears, or at distant sites, surveillance requires attention to a wider geographic area than a melanoma on, say, the lower leg. Patients are typically followed closely for at least five years, with many clinicians extending surveillance further given the elevated long-term recurrence risk.

Protecting the Scalp from UV Damage

Prevention of scalp melanoma is essentially prevention of ultraviolet damage to a body part most people forget to protect. Broad-brimmed hats are the most effective and simplest measure. A baseball cap leaves the ears and back of the neck exposed; a hat with a brim of at least three inches all around provides much better coverage. For people with thinning hair or shaved heads, applying sunscreen to the scalp is reasonable, though it is messy and easy to apply unevenly. Spray-on sunscreens and sunscreen powders designed for the hair part line exist and are worth considering for prolonged sun exposure.

UV-protective hats made from tightly woven fabrics or materials rated with a UPF (ultraviolet protection factor) of 50 or higher block at least 98% of UV radiation and are widely available. For people who work outdoors, wearing a hat consistently is probably the single most impactful habit for reducing scalp cancer risk. The sevenfold increase in scalp melanoma risk associated with pattern baldness makes this especially relevant for men experiencing hair loss. If you are balding and spend significant time in the sun without head coverage, your scalp is absorbing UV at rates comparable to your forearms or the bridge of your nose, areas most people instinctively protect.

Regular scalp checks by a dermatologist are another form of prevention, or more accurately, early detection. Annual full-body skin exams should include a thorough scalp inspection, and it is worth explicitly asking your dermatologist to check your scalp if they do not part the hair and look carefully as part of their routine. For people at higher risk due to baldness, previous skin cancers, or a history of significant sun exposure, more frequent checks may be appropriate.

1
PubMed Central. Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
2
JAMA Dermatology. Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results Program
3
Melanoma Research. Scalp melanoma is associated with high mitotic rate and is a poor prognostic factor for recurrence and outcome
4
JAMA Dermatology. Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma
5
PubMed Central. Melanoma of the Scalp and Neck: A Population-Based Analysis of Survival and Treatment Patterns
6
PubMed. Scalp melanoma: Distinctive high risk clinical and histological features
7
PubMed Central. Male pattern baldness and risk of incident skin cancer in a cohort of men
8
Scientific Reports. A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia
9
PubMed Central. Three cases of scalp melanomas discovered by hairdressers
10
PubMed. Invasive Scalp Melanoma: Role for Enhanced Detection Through Professional Training
11
PubMed Central. Flat scalp melanoma dermoscopic and reflectance confocal microscopy features correspond to histopathologic type and lesion location
12
PubMed Central. Surgical Reconstruction following Wide Local Excision of Malignant Melanoma of the Scalp
13
Dermatologic Surgery. Surgical Techniques for Closure of a Scalp Defect After Resection of Skin Malignancy
14
PubMed Central. Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma
15
PubMed Central. The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies
16
PubMed Central. Patterns of Recurrence of Cutaneous Melanoma: A Literature Review